Stay updated with breaking news from Stephen Kolb. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The Ohio State University Wexner Medical Center is one of the first nationwide to administer a targeted gene therapy for patients with a specific form of amyotrophic lateral sclerosis (ALS), a neurodegenerative disease that affects the cells in the brain and spine.
A study by researchers at The Ohio State University Wexner Medical Center and College of Medicine used a newly developed mouse model to examine the possible role of a gene called KIF5A in the development of amyotrophic lateral sclerosis (ALS).
Vogue, Saks, and the CFDA welcomed this year’s finalists with an intimate fete.
A new medication has been approved by the FDA to treat ALS, also known as Lou Gehrig’s Disease. While there’s excitement for the new medicine, it also signals just how slowly treatment of the disease is moving.